0001144204-14-027196.txt : 20140502
0001144204-14-027196.hdr.sgml : 20140502
20140502163043
ACCESSION NUMBER: 0001144204-14-027196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140430
FILED AS OF DATE: 20140502
DATE AS OF CHANGE: 20140502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synthetic Biologics, Inc.
CENTRAL INDEX KEY: 0000894158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133808303
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 155 GIBBS STREET
STREET 2: SUITE 412
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: (734) 332-7800
MAIL ADDRESS:
STREET 1: 155 GIBBS STREET
STREET 2: SUITE 412
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20081027
FORMER COMPANY:
FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20061214
FORMER COMPANY:
FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19970730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANZER STEVE H
CENTRAL INDEX KEY: 0001076653
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12584
FILM NUMBER: 14809785
4
1
v377084_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-04-30
1
0000894158
Synthetic Biologics, Inc.
SYN
0001076653
KANZER STEVE H
C/O PHARMAINVESTORS, LLC
9045 LA FONTANA BLVD, SUITE 238
BOCA RATON
FL
33434
0
0
1
1
Prior Director
Common Stock
2014-04-30
4
S
0
5003025
1.43
D
2195489
I
By: Accredited Venture Capital, LLC
Represents weighted average price per share for the toal number of shares sold. These shares were sold in multiple transactions at prices ranging from $2.01 to $1.25, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Of these shares beneficially owned, 375,246 shares are owned directly by Mr. Kanzer and 1,820,243 shares are held indirectly in the name of Accredited Venture Capital, LLC.
Mr. Kanzer is the managing member of Pharmainvestors, LLC, the managing member of Accredited Venture Capital, LLC.
/s/ Steve H. Kanzer
2014-05-02